Ryan Murr > Gibson, Dunn & Crutcher LLP > San Francisco, United States > Lawyer Profile
Gibson, Dunn & Crutcher LLP Offices
![Gibson, Dunn & Crutcher LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2024/05/GD-Wordmark-Blue-RGB_jpg-300x83.jpg?v=1716300218)
555 Mission Street, Suite 3000
San Francisco, CA 94105-0921
CALIFORNIA
United States
- Firm Profile
- Go to...
Ryan Murr
![Ryan Murr photo](https://www.legal500.com/wp-content/uploads/sites/13/2021/07/rmurr-e1717625518848-272x300.jpg)
Work Department
Life Sciences, Corporate, Capital Markets
Position
Ryan currently serves as co-chair of Gibson Dunn’s Life Sciences Practice Group, as well as co-partner-in-charge of the firm’s San Francisco office. Ryan focuses on representing operating companies and investors in the biotechnology, pharmaceutical, diagnostics and medical device industries in connection with securities offerings, corporate governance matters and business combination transactions. He serves as principal outside counsel for publicly-traded companies and venture-backed companies, advising management teams and boards of directors on general corporate matters, securities offerings, SEC reporting, corporate governance, licensing transactions and mergers & acquisitions. He also advises investment funds (private equity funds, hedge funds, venture funds and royalty buyout funds) in connection with investments in life sciences companies and assets.
Lawyer Rankings
United States > Healthcare > Life sciences
Tackling both transactions and disputes in the life sciences sector, Gibson, Dunn & Crutcher LLP is sought out by clients engaged in Hatch-Waxman and product liability litigation, in addition to those both seeking financing or seeing through M&A. Taking the lead on corporate and transactional matters is Ryan Murr, who counsels pharmaceutical, biotech and diagnostics companies on business combinations and securities transactions out of San Francisco, while New York-based Jane Love spearheads the practice’s efforts on the IP front, where she represents clients in litigation concerning biologics and small molecule therapies.
Lawyer Rankings
Top Tier Firm Rankings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Labor and employment > Labor and employment disputes (including collective actions)
- Real estate > Land use/zoning
- Media, technology and telecoms > Media and entertainment: litigation
- Transport > Aviation and air travel: finance
- Media, technology and telecoms > Outsourcing
- Transport > Rail and road: litigation and regulation
- Real estate > Real estate
- Real estate > Real estate finance
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Insurance > Advice to insurers
- Finance > Capital markets: debt offerings
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Energy > Energy transactions: electric power
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Project finance
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- Finance > Capital markets: high-yield debt offerings
- International trade > Customs, export controls and economic sanctions
- Energy > Energy litigation: oil and gas
- Energy > Energy regulation: electric power
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Industry focus > Sport
- Media, technology and telecoms > Technology transactions
- Finance > Capital markets: equity offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: electric power
- Government > Government contracts
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- Finance > Structured finance: derivatives and structured products
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Transport > Aviation and air travel: finance